BACKGROUND: It is well established that concomitant aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) has a higher operative mortality rate than isolated AVR. However, studies report conflicting results on the long-term mortality. The aim of this prospective study was to explore and compare the outcomes and risk factors of isolated AVR and concomitant AVR and CABG in a consecutive Dutch patient population. METHODS: From January 2001 through January 2010, 332 consecutive patients underwent AVR with or without CABG at a single institution (197 isolated AVR and 135 concomitant AVR and CABG). A multivariate Cox proportional hazard analysis was performed to determine the independent risk factors for long-term mortality after aortic valve replacement. RESULTS: All 332 consecutive, referred patients who underwent aortic valve surgery were followed for up to 10 years. Median follow-up length was 48 months. The population had a median age of 73 years (IQR 65-78) and predominantly consisted of males (62%). Patients in the combined AVR and CABG group were older, had worse cardiac risk profiles and had worse preoperative cardiac statuses than those receiving isolated AVR. Five-year survival was 85% in AVR and 73% in AVR-CABG (p-value 0.012). Independent risk factors for mortality were higher creatinine values, previous CABG and increasing age. CONCLUSION: Unselected, consecutive patients who underwent aortic valve replacement surgery and who received concomitant bypass surgery between 2001-2010 had higher 5-year mortality than their counterparts without CABG. Prior CABG, renal function, age but not concomitant CABG remained independently associated with increased mortality. Finally, the observed mortality rate in this consecutive patient group compared favourably with preoperative risk assessment using the EuroSCORE.
BACKGROUND: It is well established that concomitant aortic valve replacement (AVR) and coronary artery bypass grafting (CABG) has a higher operative mortality rate than isolated AVR. However, studies report conflicting results on the long-term mortality. The aim of this prospective study was to explore and compare the outcomes and risk factors of isolated AVR and concomitant AVR and CABG in a consecutive Dutch patient population. METHODS: From January 2001 through January 2010, 332 consecutive patients underwent AVR with or without CABG at a single institution (197 isolated AVR and 135 concomitant AVR and CABG). A multivariate Cox proportional hazard analysis was performed to determine the independent risk factors for long-term mortality after aortic valve replacement. RESULTS: All 332 consecutive, referred patients who underwent aortic valve surgery were followed for up to 10 years. Median follow-up length was 48 months. The population had a median age of 73 years (IQR 65-78) and predominantly consisted of males (62%). Patients in the combined AVR and CABG group were older, had worse cardiac risk profiles and had worse preoperative cardiac statuses than those receiving isolated AVR. Five-year survival was 85% in AVR and 73% in AVR-CABG (p-value 0.012). Independent risk factors for mortality were higher creatinine values, previous CABG and increasing age. CONCLUSION: Unselected, consecutive patients who underwent aortic valve replacement surgery and who received concomitant bypass surgery between 2001-2010 had higher 5-year mortality than their counterparts without CABG. Prior CABG, renal function, age but not concomitant CABG remained independently associated with increased mortality. Finally, the observed mortality rate in this consecutive patient group compared favourably with preoperative risk assessment using the EuroSCORE.
Authors: Eugene A Grossi; Charles F Schwartz; Pey-Jen Yu; Ulrich P Jorde; Gregory A Crooke; Juan B Grau; Greg H Ribakove; F Gregory Baumann; Patricia Ursumanno; Alfred T Culliford; Stephen B Colvin; Aubrey C Galloway Journal: Ann Thorac Surg Date: 2008-01 Impact factor: 4.330
Authors: David M Shahian; Sean M O'Brien; Giovanni Filardo; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Sharon-Lise T Normand; Elizabeth R DeLong; Cynthia M Shewan; Rachel S Dokholyan; Eric D Peterson; Fred H Edwards; Richard P Anderson Journal: Ann Thorac Surg Date: 2009-07 Impact factor: 4.330
Authors: J F Gummert; A Funkat; B Osswald; A Beckmann; W Schiller; A Krian; F Beyersdorf; A Haverich; J Cremer Journal: Clin Res Cardiol Date: 2009-03-05 Impact factor: 5.460
Authors: Spencer J Melby; Andreas Zierer; Scott P Kaiser; Tracey J Guthrie; Jason D Keune; Richard B Schuessler; Michael K Pasque; Jennifer S Lawton; Nader Moazami; Marc R Moon; Ralph J Damiano Journal: Ann Thorac Surg Date: 2007-05 Impact factor: 4.330
Authors: S F Fighali; A Avendaño; M A Elayda; V V Lee; C Hernandez; V Siero; R D Leachman; D A Cooley Journal: Circulation Date: 1995-11-01 Impact factor: 29.690
Authors: Jocelyn M Beach; Tomislav Mihaljevic; Lars G Svensson; Jeevanantham Rajeswaran; Thomas Marwick; Brian Griffin; Douglas R Johnston; Joseph F Sabik; Eugene H Blackstone Journal: J Am Coll Cardiol Date: 2013-02-26 Impact factor: 24.094
Authors: Giuseppe Di Gioia; Mariano Pellicano; Gabor G Toth; Filip Casselman; Julien Adjedj; Frank Van Praet; Bernard Stockman; Ivan Degrieck; Bruno Trimarco; William Wijns; Bernard De Bruyne; Emanuele Barbato Journal: J Cardiovasc Transl Res Date: 2016-02-16 Impact factor: 4.132
Authors: Ben M Swinkels; Jurriën M Ten Berg; Johannes C Kelder; Freddy E Vermeulen; Wim Jan Van Boven; Bas A de Mol Journal: Interact Cardiovasc Thorac Surg Date: 2021-01-22